Shares shifted as Atlassian (TEAM) slid to $56.48 on April 10, extending a punishing week that has seen the stock drop 17% in five sessions alone. The trigger: a formal announcement that Atlassian will be removed from the Nasdaq-100 index, the benchmark behind roughly $300 billion in tracker funds including the giant Invesco QQQ ETF. For a stock already battered by AI fears and a sector-wide software selloff, the ejection threatens a fresh wave of forced, mechanical selling — right when the company can least afford it.
A 50% Drop Shrunk Atlassian Into Index Irrelevance
Atlassian's stock fell approximately 50% during Q1 2026, shrinking its Nasdaq-100 weighting to an estimated 0.07% — a level insufficient to maintain its inclusion under the index's current methodology.
If finalized, shares will be pulled from the index at market close on April 17, 2026. That one-week countdown gives passive funds — which must mirror the index — almost no room to spread out their selling.
Index Funds Must Sell, Whether They Want To or Not
Passive index funds tracking the Nasdaq-100 are obligated to automatically sell their Atlassian holdings, and this forced selling could create a fresh wave of downward pressure on the stock. With nearly $300 billion in funds globally tracking the Nasdaq-100, including $200 billion in QQQ alone , even a tiny weighting translates to hundreds of millions in mandated liquidation — hitting a stock whose average daily trading volume is already thin relative to megacaps.
The Business Keeps Growing, But the Market Doesn't Care
Atlassian reported Q2 fiscal 2026 revenue of $1.586 billion, above analyst estimates, and cloud revenue grew 26% year over year to a first-ever $1 billion quarter. Yet the company hasn't posted a GAAP-profitable year since 2017, relying heavily on stock-based compensation equaling 25% of FY2025 revenue. It also cut 10% of its workforce — around 1,600 jobs — to fund AI and enterprise sales investments.
Wall Street Says "Buy" but Keeps Cutting Targets
Guggenheim's Howard Ma slashed his price target to $115, a near-40% cut , yet still predicts shares could nearly double and maintains a buy rating. That gap — between analyst conviction and the stock's reality at $56 — captures Atlassian's dilemma perfectly: a company growing revenue at 23% annually that the market has decided to treat like damaged goods. Earnings on April 30 are the next real test.